Valuation : Precipio, Inc.

Market Cap 46.76M 40.24M 37.86M 34.58M 64.69M 4.41B 64.87M 447M 174M 2.27B 176M 172M 7.3B P/E 2024
-1.89x
P/E 2025 -102x
Enterprise Value 47.76M 41.1M 38.67M 35.32M 66.08M 4.51B 66.26M 457M 177M 2.31B 179M 175M 7.45B EV / Sales 2024
0.44x
EV / Sales 2025 1.72x
Free-Float
87.32%
Yield 2024 *
-
Yield 2025 -
1 day+2.07%
1 week-8.41%
Current month-4.57%
1 month+16.15%
3 months+13.12%
6 months-1.51%
Current year+14.99%
1 week 24.48
Extreme 24.48
29.9
1 month 21.48
Extreme 21.48
32.57
Current year 19.22
Extreme 19.22
33.63
1 year 16
Extreme 16
33.63
3 years 3.9
Extreme 3.9
33.63
5 years 3.9
Extreme 3.9
67.6
10 years 3.9
Extreme 3.9
8,448.01
Manager TitleAgeSince
Chief Operating Officer 41 -
Chief Tech/Sci/R&D Officer 42 2017-05-31
Chief Executive Officer 54 2017-06-27
Director TitleAgeSince
Director/Board Member 54 2017-06-27
Director/Board Member 78 2017-09-25
Director/Board Member 67 2017-11-07
Date Insider Type Main position Quantity % Market Cap. Importance
7/15/26 Free

Director

520 0.0291%
7/15/26 Free

Director

416 0.0233%
7/15/26 Free

Director

108 0.0060%
Change 5-day change 1-year change 3-year change Capi.($)
+1.70%-8.41%+64.13%+300.38% 46.76M
-3.10%-6.43%+25.97%-36.22% 17.63B
+1.73%+0.02%-35.32%+61.33% 1.63B
+0.90%-4.58%-49.39%-82.47% 955M
+0.47%-2.95%-22.54%+16.82% 930M
-0.08%+0.05%+58.75%-3.84% 781M
+0.09%-3.28%-32.69%-47.27% 670M
+0.33%+9.47%-35.44%-45.57% 616M
-1.01%+4.67%-32.85%-33.78% 490M
-0.25%-6.62%+82.18%+47.57% 415M
Average +0.19%-2.13%+2.28%+17.69% 2.42B
Weighted average by Cap. -1.66%-1.83%+14.69%-26.77%

Financials

2024 2025
Net sales 18.53M 15.95M 15M 13.71M 25.64M 1.75B 25.71M 177M 68.8M 898M 69.59M 68.07M 2.89B 24.05M 20.69M 19.47M 17.79M 33.27M 2.27B 33.36M 230M 89.28M 1.16B 90.31M 88.34M 3.75B
Net income -4.29M -3.69M -3.47M -3.17M -5.94M -405M -5.95M -41.04M -15.93M -208M -16.11M -15.76M -669M -363K -312K -294K -268K -502K -34.27M -504K -3.47M -1.35M -17.58M -1.36M -1.33M -56.65M
Net Debt -136K -117K -110K -101K -188K -12.84M -189K -1.3M -505K -6.59M -511K -500K -21.22M 1M 862K 811K 741K 1.39M 94.6M 1.39M 9.59M 3.72M 48.54M 3.76M 3.68M 156M
Logo Precipio, Inc.
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Employees
66
Date Price Change Volume
26-09-04 US$26.43 +1.17% 64,062
26-09-03 US$26.12 -5.02% 423,788
26-09-02 US$27.50 -0.95% 237,052
26-09-01 US$27.77 +0.27% 211,238
26-08-31 US$27.69 -4.02% 94,501
  1. Stock Market
  2. Stocks
  3. PRPO Stock